Cytek Biosciences Inc stock is traded at $6.32, with a volume of 2,180,725. It is up +6.76% in the last 24 hours and up +20.38% over the past month. Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Previous Close:
$5.92
Open:
$5.93
24h Volume:
2,180,725
Relative Volume:
1.67
Market Cap:
$826.55M
Revenue:
$204.17M
Net Income/Loss:
-$74.00M
P/E Ratio:
-
EPS:
-$0.5775
Net Cash Flow:
-$12.84M
1W Performance:
+14.49%
1M Performance:
+20.38%
6M Performance:
+77.03%
1Y Performance:
+20.15%
1-Day Range:
$5.85$6.34
1-Week Range:
$5.41$6.34
52-Week Range:
$3.31$6.34
Cytek Biosciences Inc Stock (CTKB) Company Profile
Name
Cytek Biosciences IncSector
HealthcareIndustry
Medical DevicesPhone
(877) 922-9835Address
47215 LAKEVIEW BOULEVARD, FREMONT, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS